Sources

14 Total Sources

UniQure Wins FDA Path to Q3 Huntington's Filing Without New Trial

Left38%

Center50%

Right13%

Bloomberg30d ago

UniQure to File for Huntington's Gene Therapy Approval Without New Study After FDA Reversal

FDA lets UniQure seek accelerated approval for Huntington's therapy, shares skyrocket | Reuters

UniQure Stock Soars 75% After FDA Agrees to Gene Therapy Application Plan for Huntington's Disease

Seeking Alpha30d ago

uniQure Stock Surges as FDA Accepts AMT-130 Phase 1/2 Data for Accelerated Huntington's Approval

UniQure gets FDA nod for accelerated filing of Huntington's treatment, shares surge | WTVB | 1590 AM · 95.5 FM | The Voice of Branch County

Stocktwits30d ago

Why QURE Stock Is Soaring Today?

TipRanks30d ago

UniQure Stock (QURE) Rockets on an FDA Update - TipRanks.com

Ars Technica30d ago

FDA Overturns Rejection of UniQure's AMT-130 Gene Therapy for Huntington's Disease After Trump Official Ouster

Facebook30d ago

UniQure will submit Huntington's therapy for approval, Eli Lilly buys 4E Therapeutics, and more biotech news

tickeron.com30d ago

Why Is uniQure N.V. (QURE) Stock Up +84% Today?

Yahoo Finance30d ago

uniQure N.V. (QURE) Stock Price, News, Quote & History - Yahoo Finance

poshuk.info30d ago

AMT-130 Gene Therapy for Huntington's Disease – Results, Mechanism of Action, and FDA Status

BioPharma Dive30d ago

UniQure to File for FDA Approval of Huntington's Gene Therapy AMT-130 Amid Agency Leadership Shifts

FDA Clears UniQure to Submit Huntington's Treatment AMT-130 for U.S. Approval